Retinoblastoma: Current Practice of Care and Failure Directions for Refractory Disease |
06/04/2024 - 4:00pm to 5:00pm CDT |
Rhabdoid Tumor Predisposition Syndrome with SMARCB1 Mutation and Novel Approaches in Treatment |
04/09/2024 - 4:00pm to 5:00pm CDT |
The Texas Children's Long-Term Survivor (LTS) Program |
09/19/2023 - 4:00pm to 5:00pm CDT |
Therapy Indications in the Hematology and Oncology Population |
08/08/2023 - 11:23am CDT |
Thrombopoietin Receptor Agonists and Acute Myeloid Leukemia |
05/28/2024 - 4:00pm to 5:00pm CDT |
Thrombotic Microangiopathies: What is New in the Management of Immune-Mediated Thrombotic Thrombocytopenic Purpura |
02/13/2024 - 4:00pm to 5:00pm CST |
To Radiate or Not to Radiate? Examining the Role and Toxicities of Radiation in Non-Hodgkin Lymphoma Care |
01/16/2024 - 4:00pm to 5:00pm CST |
Treatment Options for Choroid Carcinoma |
06/25/2024 - 4:00pm to 5:00pm CDT |
Treatment-Related Osteonecrosis in Hematology/Oncology Patients: An Overview of Risk Factors, Treatment and Management Strategies |
04/16/2024 - 4:00pm to 5:00pm CDT |
Understanding School Supports Available for Hematology and Oncology Patients under Federal Law |
08/29/2023 - 4:00pm to 5:00pm CDT |